Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

VARN FAST FOUNT PLUS

NFPA

PRODUCT USE

Fountain additive for lithographic printing, diluted at approximately 2% in water.

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Considered an unlikely route of entry in commercial/industrial environments.  Accidental ingestion of the material may be damaging to the health of the individual.  Magnesium salts are generally absorbed so slowly that oral administration causes few toxic effects, as the dose is readily expelled via the bowel. If evacuation fails, mucosal irritation and absorption may result. This can result in nervous system depression, heart effects, loss of reflexes and death due to paralysis of breathing. These usually do not occur unless the bowel or kidneys are damaged.  The substance and/or its metabolites may bind to hemoglobin inhibiting normal uptake of oxygen. This condition, known as "methemoglobinemia", is a form of oxygen starvation (anoxia).  Symptoms include cyanosis (a bluish discoloration skin and mucous membranes) and breathing difficulties. Symptoms may not be evident until several hours after exposure.  At about 15% concentration of blood methemoglobin there is observable cyanosis of the lips, nose and earlobes. Symptoms may be absent although euphoria, flushed face and headache are commonly experienced. At 25-40%, cyanosis is marked but little disability occurs other than that produced on physical exertion. At 40-60%, symptoms include weakness, dizziness, lightheadedness, increasingly severe headache, ataxia, rapid shallow respiration, drowsiness, nausea, vomiting, confusion, lethargy and stupor. Above 60% symptoms include dyspnea, respiratory depression, tachycardia or bradycardia, and convulsions. Levels exceeding 70% may be fatal.  Poisonings rarely occur after oral administration of manganese salts because they are poorly absorbed from the gut.  

EYE

  Although the liquid is not thought to be an irritant, direct contact with the eye may produce transient discomfort characterized by tearing or conjunctival redness (as with windburn).  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  Inhalation may produce health damage*.  Inhalation of vapors or aerosols (mists, fumes), generated by the material during the course of normal handling, may be damaging to the health of the individual.  If exposure to highly concentrated solvent atmosphere is prolonged this may lead to narcosis, unconsciousness, even coma and possible death.  Inhalation of vapours may cause drowsiness and dizziness. This may be accompanied by narcosis, reduced alertness, loss of reflexes, lack of coordination and vertigo.  

CHRONIC HEALTH EFFECTS

  Manganese is an essential trace element. Chronic exposure to low levels of manganese can include a mask-like facial expression, spastic gait, tremors, slurred speech, disordered muscle tone, fatigue, anorexia, loss of strength and energy, apathy and poor concentration.  There has been concern that this material can cause cancer or mutations, but there is not enough data to make an assessment.  Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems.  There is some evidence that human exposure to the material may result in developmental toxicity. This evidence is based on animal studies where effects have been observed in the absence of marked maternal toxicity, or at around the same dose levels as other toxic effects but which are not secondary non-specific consequences of the other toxic effects.  Exposure to the material may cause concerns for human fertility, on the basis that similar materials provide some evidence of impaired fertility in the absence of toxic effects, or evidence of impaired fertility occurring at around the same dose levels as other toxic effects, but which are not a secondary non-specific consequence of other toxic effects..  Glyceryl triesters (triglycerides), following ingestion, are metabolised to monoglycerides, free fatty acids and glycerol, all of which are absorbed in the intestinal mucosa and undergo further metabolism. Little or no acute, subchronic or chronic oral toxicity was seen in animal studies unless levels approached a significant percentage of calorific intake. Subcutaneous injections of tricaprylin in rats over a five-week period caused granulomatous reaction characterised by oil deposits surrounded by macrophages. Diets containing substantial levels of tributyrin produced gastric lesions in rats fed for 3-35 weeks; the irritative effect of the substance was thought to be the cause of tissue damage.  Dermal application was not associated with significant irritation in rabbit skin; ocular exposures were, at most, mildly irritating to rabbit eyes. No evidence of sensitisation or photosensitisation was seen in a guinea pig maximisation test. Most of the genotoxicity test systems were negative. Tricaprylin, trioctanoin and triolein have been used, historically, as vehicles in carcinogenicity testing of other chemicals. In one study, subcutaneous injection of tricaprylin, in newborn mice, produced more tumours in lymphoid tissue than were seen in untreated animals whereas, in another study, subcutaneous or intraperitoneal injection in 4- to 6-week old female mice produced no tumours. Trioctanoin injected subcutaneously in hamster produced no tumours; when injected intraperitoneally in pregnant rats there was an increase in mammary tumours among the off-spring but similar studies in pregnant hamsters and rabbits showed no tumours in the off-spring.  The National Toxicological Program conducted a 2-year study in rats given tricaprylin by gavage. The treatment was associated with a statistically significant dose-related increase in pancreatic acinar cell hyperplasia and adenoma but there were no acinar carcinomas.  Tricaprylin is not teratogenic to mice or rats but some reproductive effects were seen in rabbits. A low level of foetal eye abnormalities and a small percentage of abnormal sperm were reported in mice injected with trioctanoin.